JY
Insider
Joseph R Young
SVP, FINANCE, CHIEF ACCT OFFCRJoseph R Young (SVP, FINANCE, CHIEF ACCT OFFCR) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vera Therapeutics, Inc. (VERA). The largest single filing was $436K of VERA (15,000 sh × $29.06, as filed), executed Nov 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$567K
shares × price, as filed
Last traded
Feb 23
Filed Feb 25
Median ADV $64.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $567K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
VERA
Vera Therapeutics, Inc.
VERA · 0 buys · 2 sells
2 filings
Recent filings
VERASALE
Vera Therapeutics, Inc.
View filing →
$131K3,117 sh × $41.98
Exec Feb 23
Filed Feb 25 · 5:30 PM ET VERASALE Vera Therapeutics, Inc. View filing → $436K
15,000 sh × $29.06
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET